Overview

Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This was a six-way crossover study with six single-dose treatment sessions. The profile of acute effects on abuse potential measures of different almorexant doses was compared to that of placebo and two doses of zolpidem
Phase:
Phase 1
Details
Lead Sponsor:
Midnight Pharma, LLC
Treatments:
Zolpidem